ARTICLE | Finance
Cidara's antimicrobial reunion
Seasoned antiinfectives team at Cidara aiming to disrupt antifungal market
July 14, 2014 7:00 AM UTC
Investors in Cidara Therapeutics Inc.'s $32 million series A round are hoping for a repeat performance by a management team with a track record of exits in the infectious disease space.
5AM Ventures led the round and was joined by Aisling Capital, Frazier Healthcare and InterWest Partners...